79295569 - ONE-STOP-SITE

Information

• Trademark
• 79295569

• Source

• Serial Number

  79295569

• Registration Number

  6458312

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  June 02, 2020
  5 years ago

• Registration Date

  August 24, 2021
  3 years ago

• Transaction Date

  May 26, 2023
  2 years ago

• Status Date

  August 24, 2021
  3 years ago

• Published for Opposition Date

  June 08, 2021
  4 years ago

• Location Date

  August 24, 2021
  3 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  SABLE, ERIC MICHAEL

• Attorney Name

  R. Peter Spies

  Law Office Assigned Location Code

  M80

• Owners

  • Scientia Limited

Case File Statements

• GS0051: Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; pharmaceutical active ingredients, namely, sold as a component ingredient of pharmaceutical preparations, and pharmaceutical preparations and compounds, all of the foregoing for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders; all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
• GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
• GS0421: Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; Consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research and development services in the pharmaceutical field; research and development services in the field of pharmaceuticals, chemical preparations, vaccines, medicines, antibodies, new products in the medical field

Case File Event Statements

• 5/26/2023 - 2 years ago

  23 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/28/2022 - 3 years ago

  22 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 2/4/2022 - 3 years ago

  21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 2/3/2022 - 3 years ago

  20 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/24/2021 - 3 years ago

  19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 8/24/2021 - 3 years ago

  18 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/8/2021 - 4 years ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/8/2021 - 4 years ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/19/2021 - 4 years ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/14/2021 - 4 years ago

  14 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 5/5/2021 - 4 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/4/2021 - 4 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/4/2021 - 4 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/4/2021 - 4 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/29/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 11/6/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/5/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 10/20/2020 - 4 years ago

  6 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 10/16/2020 - 4 years ago

  5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 10/15/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/14/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/14/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 10/8/2020 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR